| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.25 | 0.09 |